Optimizing information on drug exposure by collection of package code information in questionnaire surveys

Pharmacoepidemiology and Drug Safety

Volumn 16, Issue 9, 2007, Pages 1024-1030

  Quinzler, R ^a   Schmitt, S P W ^a   Szecsenyi, J ^a   Haefeli, W E ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Documentation; Package code information; Questionnaires

Indexed keywords

NON PRESCRIPTION DRUG;

ACCURACY; ADULT; AGED; ARTICLE; DRUG EXPOSURE; DRUG INFORMATION; DRUG LABELING; DRUG PACKAGING; DRUG UTILIZATION; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; PHARMACOEPIDEMIOLOGY; PRIORITY JOURNAL;

AGED; DATA COMPRESSION; DRUG INDUSTRY; DRUG INFORMATION SERVICES; DRUG LABELING; DRUG PACKAGING; FEMALE; GERMANY; HUMANS; MALE; MIDDLE AGED; QUESTIONNAIRES; TIME FACTORS;

EID: 34548717116     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1406     Document Type: Article

References (15)

1. Bergk V, Gasse C, Rothenbacher D, et al. Drug interactions in primary care: impact of a new algorithm on risk determination. Clin Pharmacol Ther 2004; 76: 85-96.
2. Falconnier AD, Haefeli WE, Schoenenberger RA, et al. Drug dosage in patients with renal failure optimized by immediate concurrent feedback. J Gen Intern Med 2001; 16: 369-375.
3. Fick DM, Cooper JW, Wade WE, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 2003; 163: 2716-2724.
4. Knaup P, Pilz J, Kaltschmidt J, Ludt S, et al. Standardized documentation of drug recommendations in discharge letters: a contribution to quality management in cooperative care. Methods Inf Med 2006; 45: 336-342.
5. Pahor M, Chrischilles EA, Guralnik JM, Brown SL, et al. Drug data coding and analysis in epidemiologic studies. Eur J Epidemiol 1994; 10: 405-411.
6. Walop W, Semenchuk M. Coding of drugs used by respondents of the Canadian study of health and aging. Can J Clin Pharmacol. 2002; 9: 64-68.
7. Quinzler R, Gasse C, Schneider A, et al. The frequency of inappropriate tablet splitting in primary care. Eur J Clin Pharmacol. 2006; 62: 1065-1073.
8. MMI Pharmindex Datenbestand Version 2005 July 15 [compact disc]. Medizinische Medien Informations GmbH, Neu-Isenburg.
9. Philips L. Hanging on the metaphone. Computer Language 1990; 7: 39-43.
10. Levenshtein VI. Binary codes capable of correcting deletions, insertions, and reversals. Doklady Akademii Nauk SSSR 1965; 163: 845-848.
11. European Agency for the Evaluation of Medicinal Products. Committee for proprietary medicinal products (CPMP). Note for guidance on the investigation of bioavailability and bioequivalence. Available from: http://www.emea.eu.int/pdfs/human/ewp/140198en.pdf [July 24, 2006].
12. Rashed SM, Nolly RJ, Robinson L, Thoma L. Weight variability of scored and unscored split psychotropic drug tablets. Hosp Pharm 2003; 38: 930-934.
13. Aman W, Thoma K. How to photostabilize molsidomine tablets. J Pharm Sci 2004; 93: 1860-1866.
14. Silberstein SD, Dodick D, Kesslick J. Removing barriers to appropriate migraine treatment: formulary limitations and triptan package size. Headache 2005; 45: 1250-1254.
15. Thomson WM. A medication capture and analysis system for use in epidemiology. Drugs Aging 1997; 10: 290-298.